These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
124 related articles for article (PubMed ID: 6788164)
1. Vitamin A toxicity and hypercalcaemia in chronic renal failure. Farrington K; Miller P; Varghese Z; Baillod RA; Moorhead JF Br Med J (Clin Res Ed); 1981 Jun; 282(6281):1999-2002. PubMed ID: 6788164 [TBL] [Abstract][Full Text] [Related]
2. The effects of vitamin A toxicity on calcium and lipid metabolism in chronic renal failure. Miller P; Sweny P; Persaud JW; Varghese Z; Farrington K; Chan MK; Baillod RA; Moorhead JF Proc Eur Dial Transplant Assoc; 1981; 18():573-8. PubMed ID: 7036172 [TBL] [Abstract][Full Text] [Related]
3. [Hypercalcemia due to chronic vitamin A use by an elderly patient with renal insufficiency]. Beijer C; Planken EV Ned Tijdschr Geneeskd; 2001 Jan; 145(2):90-3. PubMed ID: 11225264 [TBL] [Abstract][Full Text] [Related]
4. Hypercalcaemia after oral calcium-carbonate therapy in patients on chronic haemodialysis. Ginsburg DS; Kaplan EL; Katz AI Lancet; 1973 Jun; 1(7815):1271-4. PubMed ID: 4126071 [No Abstract] [Full Text] [Related]
5. Transient and persistent hypercalcaemia in patients treated by maintenance haemodialysis. Wing AJ; Curtis JR; Eastwood JB; Smith EK; de Wardener HE Br Med J; 1968 Oct; 4(5624):150-2. PubMed ID: 5681049 [TBL] [Abstract][Full Text] [Related]
6. [Hypercalcaemic crises in patients with chronic renal failure caused by ion-exchange resins, antacidotics and other calcium-containing drugs (author's transl)]. Graben N; Cremer W; Anlauf M; Bock KD Dtsch Med Wochenschr; 1977 Dec; 102(52):1903-7. PubMed ID: 598299 [TBL] [Abstract][Full Text] [Related]
7. Relationship between vitamin A and bone disease in chronic renal failure. Rylance PB; Brown IR; Howells DW; Nisbet JA; Stone AN; Eastwood JB Nephron; 1984; 36(2):131-5. PubMed ID: 6537995 [TBL] [Abstract][Full Text] [Related]
8. Calcium metabolism and hyperparathyroidism after renal transplantation. Cundy T; Kanis JA; Heynen G; Morris PJ; Oliver DO Q J Med; 1983; 52(205):67-78. PubMed ID: 6348830 [TBL] [Abstract][Full Text] [Related]
9. Daily oral 25-hydroxycholecalciferol supplementation for vitamin D deficiency in haemodialysis patients: effects on mineral metabolism and bone markers. Jean G; Terrat JC; Vanel T; Hurot JM; Lorriaux C; Mayor B; Chazot C Nephrol Dial Transplant; 2008 Nov; 23(11):3670-6. PubMed ID: 18579534 [TBL] [Abstract][Full Text] [Related]
10. Serum vitamin A levels and associated abnormalities in patients on regular dialysis treatment. Werb R; Clark WF; Lindsay RM; Jones EO; Linton AL Clin Nephrol; 1979 Aug; 12(2):63-8. PubMed ID: 527272 [TBL] [Abstract][Full Text] [Related]
11. Plasma retinol and retinol binding protein concentrations in patients on maintenance haemodialysis with and without vitamin A supplements. Stewart WK; Fleming LW Nephron; 1982; 30(1):15-21. PubMed ID: 7201081 [TBL] [Abstract][Full Text] [Related]
12. Hypercalcaemia from calcium ion-exchange resin in patients on regular haemodialysis. Papadimitriou M; Gingell JC; Chisholm GD Lancet; 1968 Nov; 2(7575):948-50. PubMed ID: 4176266 [No Abstract] [Full Text] [Related]
13. Impact of vitamin D replacement in patients with normocalcaemic and hypercalcaemic primary hyperparathyroidism and coexisting vitamin D deficiency. Das G; Eligar V; Govindan J; Bondugulapati LN; Okosieme O; Davies S Ann Clin Biochem; 2015 Jul; 52(Pt 4):462-9. PubMed ID: 25468998 [TBL] [Abstract][Full Text] [Related]
14. An investigation of biochemical and radiographic signs of hyperparathyroidism in chronic renal disease. Nilsson P; Malmaeus J; Wide L; Danielson BG Scand J Urol Nephrol Suppl; 1984; 84():I1-25. PubMed ID: 6393321 [TBL] [Abstract][Full Text] [Related]
16. Acute kidney injury due to excessive and prolonged intramuscular injection of veterinary supplements containing vitamins A, D and E: A series of 16 cases. De Francesco Daher E; Mesquita Martiniano LV; Lopes Lima LL; Viana Leite Filho NC; de Oliveira Souza LE; Duarte Fernandes PH; da Silva SL; da Silva Junior GB Nefrologia; 2017; 37(1):61-67. PubMed ID: 27577045 [TBL] [Abstract][Full Text] [Related]
17. Plasma vitamin A in haemodialysis patients. De Bevere VO; De Paepe M; De Leenheer AP; Nelis HJ; Lambert WE; Claeys AE; Ringoir S Clin Chim Acta; 1981 Aug; 114(2-3):249-56. PubMed ID: 7285348 [TBL] [Abstract][Full Text] [Related]
18. Vitamin A toxicity and hypercalcaemia in chronic renal failure. O'Fearghail M; Walker JF; Cronin CJ Br Med J (Clin Res Ed); 1981 Oct; 283(6296):919. PubMed ID: 6793176 [No Abstract] [Full Text] [Related]
19. 1alpha(OH)D3 One-alpha-hydroxy-cholecalciferol--an active vitamin D analog. Clinical studies on prophylaxis and treatment of secondary hyperparathyroidism in uremic patients on chronic dialysis. Brandi L Dan Med Bull; 2008 Nov; 55(4):186-210. PubMed ID: 19232159 [TBL] [Abstract][Full Text] [Related]
20. Hypervitaminosis A toxicity in regular hemodialysis patients. Ono K Trans Am Soc Artif Intern Organs; 1984; 30():40-3. PubMed ID: 6543480 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]